You are here

Eli Lilly

R&D round-up: Non-opioid painkiller space heats up

Pharmaforum

Sat, 03/16/19 - 12:38 pm

non-opioid pain treatments

Kings College London

Lilly CEO David Ricks snags $17.2M pay package for 2018, a 9% hike

Fierce Pharma

Wed, 03/13/19 - 11:22 pm

Lilly's combo treatment meets main goal in lung cancer late-stage study

Yahoo/Reuters

Tue, 03/12/19 - 10:12 am

clinical trials

metastatic non-small cell lung cancer

How Much Difference Will Eli Lilly's Half-Price Insulin Make?

NPR

Sun, 03/10/19 - 12:04 pm

3 Big Pharmas Trying to Pop the Rebate Bubble

Motley Fool

Wed, 03/6/19 - 10:06 am

Gilead Sciences

Lilly claims fast FDA review for Emgality in cluster headache

Pharmaforum

Tue, 03/5/19 - 11:55 am

episodic cluster headache

Lilly will sell a version of its popular insulin at half the price, but will this appease critics?

Stat

Mon, 03/4/19 - 10:23 am

In a blockbuster franchise race, Novo’s Trulicity rival scores more promising late-stage diabetes data

Endpoints

Mon, 03/4/19 - 10:20 am

Johnson & Johnson keeps the heat on Tremfya's rivals with at-home injector nod

Fierce Pharma

Fri, 03/1/19 - 11:56 am

Biogen, BioMarin, Lilly and Bristol-Myers Could Be in Crosshairs of Acquirers

Yahoo/Guru Focus

Sun, 02/24/19 - 11:36 pm

Bristol-Myers Squibb

Higher dose of Pfizer-Lilly drug helps reduce back pain in study

Yahoo/Reuters

Tue, 02/19/19 - 09:54 am

chronic low back pain

clinical trials

opioid alternatives

Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo

Yahoo/Reuters

Fri, 02/15/19 - 10:27 am

Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride

Pharmaceutical Business Review

Fri, 02/15/19 - 10:13 am

Boehringer Ingelheim

type 2 diabetes

clinical trials

Pharma companies clear the R&D decks in Q4

Pharmaforum

Mon, 02/11/19 - 12:20 pm

Gilead Sciences

Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal

TheStreet.com

Wed, 02/6/19 - 09:47 am

Lilly and Incyte's Olumiant Hits the Mark in Two Phase III Atopic Dermatitis Trials

BioSpace

Mon, 02/4/19 - 11:49 am

atopic dermatitis

clinical trials

Here's Why Array BioPharma Jumped 31% in January

Motley Fool

Mon, 02/4/19 - 09:53 am

Array Biopharma

Upcoming events – Ascendis and Lilly hope for growth with pivotal data

EP Vantage

Fri, 02/1/19 - 11:58 am

clinical trials

pediatric growth hormone deficiency

Eli Lilly Loxo Oncology Transaction Clears A Hurdle

CP Wire

Fri, 02/1/19 - 09:48 am

Eli Lilly Loxo Oncology Transaction Clears A Hurdle

Fri, 02/1/19 - 09:43 am

Pages